Pezcoller foundation-AACR international award for cancer research Lecture

5 maggio 2017
Versione stampabile

At 2 p.m.
Venue:Polo scientificio e tecnologico F. Ferrari - Room B107

2017 RECIPIENT

David M. Livingston, MD Deputy Director, Dana-Farber/Harvard Cancer Center, Executive Committee Department of Cancer Biology, Dana-Farber Cancer Institute
Boston, USA

The 2017 Award recipient, Dr. David M. Livingston is recognized for his fundamental contributions to the field of basic cancer research. His work has been pivotal to the understanding of the retinoblastoma pathway in cell cycle control as well as the transcriptional co-activation function of the key regulatory proteins p300 and CBP.

Dr. Livingston is also credited with the landmark discovery of the central functions of the tumor suppressors BRCA1 and BRCA2, which has revolutionized the field of breast and ovarian cancer research.

THE PEZCOLLER FOUNDATION
Is a non-profit organization created in 1980 by Prof. Alessio Pezcoller (1896 - 1993) Chief Surgeon of Santa Chiara Hospital of Trento, Italy. The goal of the Foundation is to promote biomedical research in the field of cancer.

THE AACR
Founded in 1907, the American Association for Cancer Research (AACR) is the world’s oldest and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer.

 

Co-organized with